Prediction of Duration of Mechanical Ventilation in ARDS
NCT ID: NCT05993377
Last Updated: 2024-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1303 participants
OBSERVATIONAL
2023-08-14
2024-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Artificial Intelligence Models for Predicting The Need for Intubation and Successful Weaning From Mechanical Ventilation in ICU Patients
NCT07065838
Artificial Intelligence in Categorizing the Severity of Oxygenation by Incorporating the PEEP Into the Definition of ARDS in Ventilated Patients
NCT05371314
Incidence of Dyssynchronies in Early ARDS
NCT03447288
Prevention of Lung Injury Induced by Mechanical Ventilation in Acute Respiratory Distress Syndrome ARDS Patients
NCT06835881
Development of a Scoring and Prediction Model for Weaning Success in ARDS Patients Using Ventilation Parameters Combined with Artificial Intelligence and Deep Learning Techniques
NCT06751693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For model description and testing, the investigators will extract data from he first three ICU days after diagnosis of moderate-to-severe ARDS from patients included in the de-identified database, which includes 1,000 mechanically ventilated patients enrolled in several observational cohorts in Spain, coordinated by the principal investigator (JV), and funded by the Instituto de Salud Carlos III (ISCIII). The investigators will follow the TRIPOD guidelines and machine learning techniques will be implemented \[Random Forest (RF), eXtreme Gradient Boosting (XGBoost), and Logistic regression analysis) for the development and accuracy of prediction models. Disease progression will be tracked along those 3 ICU days to assess lung severity according to Berlin criteria. For external validation, the investigators will use 303 patients enrolled in a contemporary observational study (NCT03145974). The investigators will evaluate the accuracy of prediction models by calculation several statistics, such as sensitivity, specificity, positive predictive value, negative value for each model. The investigators will select the best early prediction model with data captured on the 1st, 2nd, or 3rd day.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Derivation and testing cohort
It will contain 1000 ARDS patients
Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .
we will use robust machine learning approaches, such as Random Forest and XGBoost.
Confirmatory cohort
It will contain 303 patients (for external validation)
Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .
we will use robust machine learning approaches, such as Random Forest and XGBoost.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .
we will use robust machine learning approaches, such as Random Forest and XGBoost.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* brain death patients
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Cardiff University
OTHER
Leiden University Medical Center
OTHER
Dr. Negrin University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jesus Villar
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jesús Villar
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario D. Negrin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Dr. Negrin
Las Palmas de Gran Canaria, Las Palmas, Spain
Hospital Universitario Puerta de Hierro (ICU)
Majadahonda, Madrid, Spain
Hospital Universitario NS de Candelaria
Santa Cruz de Tenerife, Tenerife, Spain
Hospital NS del Prado
Talavera de la Reina, Toledo, Spain
Hospital Universitario de A Coruña (ICU)
A Coruña, , Spain
Complejo Hospitalario Universitario de Albacete (ICU)
Albacete, , Spain
Complejo Hospitalario de Albacete
Albacete, , Spain
Department of Anesthesia, Hospital Clinic
Barcelona, , Spain
Hospital General de Ciudad Real (ICU)
Ciudad Real, , Spain
Hospital Virgen de La Luz
Cuenca, , Spain
Complejo Hospitalario Universitario de León
León, , Spain
Hospital Universitario Ramón y Cajal (Anesthesia)
Madrid, , Spain
Hospital Universitario La Paz (ICU)
Madrid, , Spain
Hospital Fundación Jiménez Díaz
Madrid, , Spain
Hospital Universitario Regional de Malaga Carlos Haya (ICU)
Málaga, , Spain
Hospital Universitario Carlos Haya
Málaga, , Spain
Hospital Universitario Virgen de Arrixaca (ICU)
Murcia, , Spain
Hospital Universitario Río Hortega (ICU)
Valladolid, , Spain
Hospital Virgen de la Concha (ICU)
Zamora, , Spain
Cardiff University
Cardiff, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Villar J, Ambros A, Mosteiro F, Martinez D, Fernandez L, Ferrando C, Carriedo D, Soler JA, Parrilla D, Hernandez M, Andaluz-Ojeda D, Anon JM, Vidal A, Gonzalez-Higueras E, Martin-Rodriguez C, Diaz-Lamas AM, Blanco J, Belda J, Diaz-Dominguez FJ, Rico-Feijoo J, Martin-Delgado C, Romera MA, Gonzalez-Martin JM, Fernandez RL, Kacmarek RM; Spanish Initiative for Epidemiology, Stratification and Therapies of ARDS (SIESTA) Network. A Prognostic Enrichment Strategy for Selection of Patients With Acute Respiratory Distress Syndrome in Clinical Trials. Crit Care Med. 2019 Mar;47(3):377-385. doi: 10.1097/CCM.0000000000003624.
Figueroa-Casas JB, Dwivedi AK, Connery SM, Quansah R, Ellerbrook L, Galvis J. Predictive models of prolonged mechanical ventilation yield moderate accuracy. J Crit Care. 2015 Jun;30(3):502-5. doi: 10.1016/j.jcrc.2015.01.020. Epub 2015 Jan 30.
Villar J, Gonzalez-Martin JM, Fernandez C, Soler JA, Ambros A, Pita-Garcia L, Fernandez L, Ferrando C, Arocas B, Gonzalez-Vaquero M, Anon JM, Gonzalez-Higueras E, Parrilla D, Vidal A, Fernandez MM, Rodriguez-Suarez P, Fernandez RL, Gomez-Bentolila E, Burns KEA, Szakmany T, Steyerberg EW, The PredictION Of Duration Of mEchanical vEntilation In Ards Pioneer Network. Predicting the Length of Mechanical Ventilation in Acute Respiratory Disease Syndrome Using Machine Learning: The PIONEER Study. J Clin Med. 2024 Mar 21;13(6):1811. doi: 10.3390/jcm13061811.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PIFIISC21-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.